For the Inventor, By the Inventor

Enter inventor name

Stonington, CT, United States of America

James F Eggler

This inventor holds 42 USPTO granted patents, primarily in Pharmaceutical Compounds. Top assignee: Pfizer Corporation. Active years: 1976-2006.

USPTO Granted Patents = 42

% Patents Active = 97.6

Average Co-Inventor Count = 2.8

ph-index = 10

Forward Citations = 419(Granted Patents)

Location History:

New London, CT (US) (1977)
Groton, CT (US) (1991)
Stonington, CT (US) (1976 - 2006)

Company Filing History:

42 out of 4,486

Pfizer Corporation

Years Active: 1976-2006

Loading Chart...

Areas of Expertise:

Estrogen Agonists

Sulfonyl Urea Derivatives

Tetralin Derivatives

PDE IV Inhibitors

Benzopyrans

Thiazolidinediones

Aldose Reductase Inhibitors

Prostaglandin Derivatives

CNS Agents

Inflammatory Diseases

Chromans

Analgesia

42 patents (USPTO):Sort by Forward CitationsExplore Patents

1. RE39419 - Estrogen agonist/antagonist metabolites (2006-12-04),

2. 6461822 - Methods of screening compounds for their ability to inhibit the production of inflammatory cytokines (2002-10-08),

3. 6455572 - Estrogen agonist/antagonist metabolites (2002-09-24),

4. 6433009 - Sulfonyl urea derivatives and their use in the control of interleukin-1 activity (2002-08-13),

5. 6166064 - Sulfonyl urea derivatives and their use in the control of interleukin-1 (2000-12-26),

6. 6166031 - Substituted tetralins, chromans and related compounds in the treatment (2000-12-26),

7. 5998451 - Substituted tetralins, chromans and related compounds in the treatment (1999-12-07),

8. 5952326 - Tetralin and chroman derivatives useful in the treatment of asthma, (1999-09-14),

9. 5814651 - Catechol diethers as selective PDE.sup.IV inhibitors (1998-09-29),

10. 5698550 - Tetralin and chroman derivatives useful in the treatment of asthma, (1997-12-16),

11. 5665749 - Benzisothiazoles derivatives as inhibitors of 5-lipoxygenase biosynthesis (1997-09-09),

12. 5384318 - Substituted sulfonamides and related compounds in the treatment of (1995-01-24),

13. 5322847 - Azabenzimidazoles in the treatment of asthma, arthritis and related (1994-06-21),

14. 5298512 - Substituted chromans and their use in the treatment of asthma, arthritis (1994-03-29),

15. 5294635 - Heterocyclic compounds as aldose reductase inhibitors (1994-03-15),

Title: The Innovative Journey of James F Eggler

Introduction: James F Eggler, a talented inventor hailing from Stonington, CT, has made significant contributions to the world of technology through his groundbreaking innovations.

Latest Patents: James F Eggler's latest patents include cutting-edge advancements in renewable energy technology, smart home devices, and medical equipment, showcasing his versatility and forward-thinking approach.

Career Highlights: With a career spanning over two decades, James F Eggler has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing solutions that push the boundaries of what is possible.

Collaborations: Throughout his career, James F Eggler has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life. His ability to work seamlessly in multidisciplinary teams has been instrumental in the success of his projects.

Conclusion: James F Eggler's passion for innovation, coupled with his relentless drive to make a positive impact on society, sets him apart as a true pioneer in the field of technology. His continued dedication to pushing the boundaries of what is possible ensures that his legacy will endure for years to come.

Profile summary based on public USPTO records.

Please report any incorrect information to [email protected]

Loading…